Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Davidson (1998)
Pharmacotherapy of social anxiety disorder.The Journal of clinical psychiatry, 59 Suppl 17
T. Kruger, M. Magid, M. Wollmer (2016)
Can Botulinum Toxin Help Patients With Borderline Personality Disorder?The American journal of psychiatry, 173 9
(2019)
The link between facial feedback and neural activity within central circuitries of emotion—new www.psychopharmacology.com 411 eserved
M. Wollmer, C. Boer, N. Kalak, J. Beck, T. Götz, T. Schmidt, M. Hodzic, U. Bayer, T. Kollmann, K. Kollewe, D. Sönmez, K. Duntsch, M. Haug, M. Schedlowski, M. Hatzinger, D. Dressler, S. Brand, E. Holsboer-trachsler, T. Kruger (2012)
Facing depression with botulinum toxin: a randomized controlled trial.Journal of psychiatric research, 46 5
E. Finzi, Erika Wasserman (2006)
Treatment of Depression with Botulinum Toxin A: A Case SeriesDermatologic Surgery, 32
A. Hennenlotter, C. Dresel, F. Castrop, A. Ceballos-Baumann, A. Wohlschläger, B. Haslinger (2009)
The link between facial feedback and neural activity within central circuitries of emotion--new insights from botulinum toxin-induced denervation of frown muscles.Cerebral cortex, 19 3
H. Stallman, M. Kohler (2016)
Prevalence of Sleepwalking: A Systematic Review and Meta-AnalysisPLoS ONE, 11
E. Finzi, N. Rosenthal (2016)
Emotional proprioception: Treatment of depression with afferent facial feedback.Journal of psychiatric research, 80
H. Stallman, M. Kohler, A. Wilson, S. Biggs, J. Dollman, J. Martin, D. Kennedy, K. Lushington (2016)
Self-reported sleepwalking in Australian senior secondary school students.Sleep medicine, 25
T. Williams, Coenraad Hattingh, Catherine Kariuki, S. Tromp, A. Balkom, J. Ipser, D. Stein (2017)
Pharmacotherapy for social anxiety disorder (SAnD).The Cochrane database of systematic reviews, 10
M. Kim, M. Neta, F. Davis, Erika Ruberry, D. Dinescu, T. Heatherton, M. Stotland, P. Whalen (2014)
Botulinum toxin-induced facial muscle paralysis affects amygdala responses to the perception of emotional expressions: preliminary findings from an A-B-A designBiology of Mood & Anxiety Disorders, 4
E. Finzi, N. Rosenthal (2014)
Treatment of depression with onabotulinumtoxinA: a randomized, double-blind, placebo controlled trial.Journal of psychiatric research, 52
E. Finzi, L. Kels, J. Axelowitz, B. Shaver, C. Eberlein, T. Krueger, M. Wollmer (2018)
Botulinum toxin therapy of bipolar depression: A case series.Journal of psychiatric research, 104
Justin Kim, R. Loucks, Amy Palmer, Annemarie Brown, Kimberly Solomon, shley Marchante, P. Whalen (2011)
The structural and functional connectivity of the amygdala: From normal emotion to pathological anxietyBehavioural Brain Research, 223
M. Magid, J. Reichenberg, Poppy Poth, H. Robertson, Amanda LaViolette, T. Kruger, M. Wollmer, M. Wollmer (2014)
Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study.The Journal of clinical psychiatry, 75 8
K. Connor, Jonathan Cook, J. Davidson (2006)
Botulinum toxin treatment of social anxiety disorder with hyperhidrosis: a placebo-controlled double-blind trial.The Journal of clinical psychiatry, 67 1
Letters to the Editors Journal of Clinical Psychopharmacology Volume 39, Number 4, July/August 2019 2. Stallman HM, Kohler M, Wilson A, et al. BT into the glabellar region between May DISCUSSION Self-reported sleepwalking in Australian senior 2017 and October 2018. None of the pa- Guanfacine may suppress rapid eye move- secondary school students. Sleep Med. tients had hyperhidrosis. In 5 patients, ment sleep, modulate sleep architecture, 2016;25:1–3. previous and current pharmacologic and and can result in less sleepwalking. As a se- 3. De Cock VC. Sleepwalking. Curr Treat Options psychotherapeutic treatments had either lective α-adrenergic 2A agonist, it has the Neurol. 2016;18:1–9. been insufficient or were discontinued ability to regulate glutamatergic and catechol- secondary to side effects. All patients 4. Stallman HM, Kohler M. A systematic amine systems, both implicated in the neuro- review of treatments for sleepwalking: were maintained on their existing treat- chemistry of sleepwalking. Benzodiazepines 100 years of case studies. Sleep Hypnosis. ment regimen, and written consent was lessen sleepwalking through a sedative- 2016;1–22. obtained. SAnD symptoms were assessed hypnotic effect. Antidepressant medications 5. Fredriksson I, Jayaram-Lindström N, Wirf M, by the Leibowitz Social Anxiety Scale are thought to decrease sleepwalking owing et al. Evaluation of
Journal of Clinical Psychopharmacology – Wolters Kluwer Health
Published: Jan 1, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.